This agreement covers all European territories, reinforcing the two companies’ position as leading providers of scientifically supported probiotics for women’s health Lallemand Health Solutions and Proge Farm announced a new…

This agreement covers all European territories, reinforcing the two companies’ position as leading providers of scientifically supported probiotics for women’s health

Lallemand Health Solutions and Proge Farm announced a new milestone in their partnership: after remarkable after-sales success across the extra-EU market, the two companies have signed a new agreement on L. plantarum PROGE P17630 for oral use.

This agreement covers all European territories, reinforcing the two companies’ position as leading providers of scientifically supported probiotics for women’s health. The strain, originally licensed from Proge Farm to Lallemand for Asia, the Americas, France, and the Czech Republic under the first agreement signed on June 30, 2020, is now available as Lactiplantibacillus plantarum P17630 in Europe, also inside Lallemand’s blends.

Mirabel, Canada, December 12, 2025 – “This achievement reflects the strong market adoption and trust in Lactiplantibacillus plantarum PROGE P17630 as a natural solution for women’s intimate health. Expanding our licensing rights worldwide allows us to deliver this unique strain to more women seeking effective, convenient oral probiotics,” said Isabelle Champié, Vice President Sales and Marketing at Lallemand Health Solutions.

Novara, Italy, December 12, 2025 – “We are proud to strengthen our collaboration with Lallemand Health Solutions, a global leader in probiotics. Following the registration in Europe of our Live Biotherapeutic Product for vaginal use based on our Lactiplantibacillus plantarum P17630, this agreement reinforces the possibility for our strain to reach women everywhere, also for oral administration, improving quality of life through science-backed solutions” added Giancarla Dondi, CEO of Proge Farm.

With this new agreement, Proge Farm and Lallemand Health Solutions strengthen their leadership in the women’s health probiotics segment, a fast-growing niche driven by consumer demand for natural, effective solutions for intimate health. Proge Farm and Lallemand share the same approach, combining scientific rigour, regulatory expertise, and global reach to deliver premium probiotic solutions that improve women’s quality of life.